Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Heart Failure Diagnostic And Monitoring Device Market: By Product, By Tests, Echocardiogram, Stress Test, Cardiac Computerized Tomography Scan or Magnetic Resonance Imaging, Coronary Angiogram, and Myocardial Biopsy) and Geography
Heart Failure Diagnostic And Monitoring Device Market size was valued at US$ 3,936.8 million in 2023 and is poised to grow at a significant CAGR of 4.8% over 2024–2030. Heart failure, also known as congestive heart failure, is a condition that develops when the heart muscle is unable to pump blood effectively or when it results in other states, including high blood pressure, high cholesterol, blood vessel narrowing, and others. The diagnosis of heart failure can be made in several ways, including blood tests, chest x-rays, echocardiograms, and others. The incidence of heart failure is rising, as are other conditions like diabetes, atherosclerosis, stroke, hypertension, and others.
The market is also growing due to sedentary lifestyle habits, technological advancements in cardiac heart failure treatment devices, and the number of older adults. However, several obstacles limit the market's growth, including reimbursement concerns and the high cost of diagnosing appliances in emerging economies. Shortly, new emerging technology in cardiovascular treatment & diagnostics will create many chances in undiscovered areas. The future market expansion for ambulatory cardiac monitoring devices is being aided by the increasing demand for cutting-edge cardiac equipment, including Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry. The market for ambulatory cardiac monitoring devices is also driven by favorable reimbursement policies, increasing government and individual healthcare spending, and other essential factors.
Key businesses implement different tactics to broaden product offerings and global geographic presence. Companies use various techniques to increase their market presence, including product portfolio growth, mergers and acquisitions, technological breakthroughs, and increased research and development. For instance, in August 2021, Advanced Medical Predictive Devices, (AMP3D), Diagnostics and Displays Inc.'s extensive library of clinical predictive algorithms and one-of-a-kind software-as-a-service (SaaS) platform were acquired by Nihon Kohden. In order to depict real-time and continuous risk trajectories, AMP3D's CoMET software makes use of patient continuous monitoring data, vital signs, medical records, and laboratory test data.
Heart Failure Diagnostic And Monitoring Device Market Key Developments:
Study Period
2024 - 2030Base Year
2023CAGR
4.8%Largest Market
Asia PacificFastest Growing Market
North America
Growing adherence to destructive lifestyles, such as rising nicotine and cigarette use, unhealthy food consumption, and increasing body mass index, contribute to the rise in heart failure cases and the growth of heart failure testing. The most frequent causes of the market expansion for heart failure monitoring devices are rising rates of disorders like diabetes and hypertension. Another reason anticipated to fuel the expansion of the heart failure diagnostic and monitoring device market is the rising prevalence of coronary artery disorders. The main factors influencing the market's growth are the increasing obesity rate and the aging population. On the other hand, due to the hazards connected with this technology, the FDA has regulatory oversight over the market for heart failure monitoring and diagnostic devices.
Report Benchmarks |
Details |
Report Study Period |
2024 - 2030 |
Market Size in 2023 |
US$ 3,936.8 million |
Market CAGR |
4.8% |
By Product Type |
|
By Test Type |
|
By Region |
|
Download Free Sample Report
The heart failure diagnostic and monitoring device market is projected to expand at a CAGR of 4.8% during the forecast period
Abbott Laboratories, Beckman Coulter, Abiomed Inc., Berlin Heart GmbH, Biotronik SE and Co. KG, Boston Scientific Corporation
North America is the fastest-growing region for heart failure diagnostic and monitoring device market
1.Executive Summary |
2.Global Heart Failure Diagnostic And Monitoring Device Market Introduction |
2.1.Global Heart Failure Diagnostic And Monitoring Device Market - Taxonomy |
2.2.Global Heart Failure Diagnostic And Monitoring Device Market - Definitions |
2.2.1.By Product Type |
2.2.2.By Test Type |
2.2.3.By Geography |
2.2.4.Region |
3.Global Heart Failure Diagnostic And Monitoring Device Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Heart Failure Diagnostic And Monitoring Device Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Heart Failure Diagnostic And Monitoring Device Market By By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. ECG Systems |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Holter Monitors |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Event Monitors |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Implantable Loop Recorders |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Heart Failure Diagnostic And Monitoring Device Market By By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Blood Tests |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Chest X-Ray |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Electrocardiogram (ECG) |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Echocardiogram |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Stress Test |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI) |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Coronary Angiogram |
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Myocardial Biopsy |
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
7.Global Heart Failure Diagnostic And Monitoring Device Market By By Geography, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. The Asia Pacific |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. MEA |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.Global Heart Failure Diagnostic And Monitoring Device Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. By Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.ECG Systems |
9.1.2.Holter Monitors |
9.1.3.Event Monitors |
9.1.4.Implantable Loop Recorders |
9.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Blood Tests |
9.2.2.Chest X-Ray |
9.2.3.Electrocardiogram (ECG) |
9.2.4.Echocardiogram |
9.2.5.Stress Test |
9.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI) |
9.2.7.Coronary Angiogram |
9.2.8.Myocardial Biopsy |
9.3. By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.North America |
9.3.2.Europe |
9.3.3.The Asia Pacific |
9.3.4.Latin America |
9.3.5.MEA |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. By Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.ECG Systems |
10.1.2.Holter Monitors |
10.1.3.Event Monitors |
10.1.4.Implantable Loop Recorders |
10.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Blood Tests |
10.2.2.Chest X-Ray |
10.2.3.Electrocardiogram (ECG) |
10.2.4.Echocardiogram |
10.2.5.Stress Test |
10.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI) |
10.2.7.Coronary Angiogram |
10.2.8.Myocardial Biopsy |
10.3. By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.North America |
10.3.2.Europe |
10.3.3.The Asia Pacific |
10.3.4.Latin America |
10.3.5.MEA |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. By Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.ECG Systems |
11.1.2.Holter Monitors |
11.1.3.Event Monitors |
11.1.4.Implantable Loop Recorders |
11.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Blood Tests |
11.2.2.Chest X-Ray |
11.2.3.Electrocardiogram (ECG) |
11.2.4.Echocardiogram |
11.2.5.Stress Test |
11.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI) |
11.2.7.Coronary Angiogram |
11.2.8.Myocardial Biopsy |
11.3. By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.North America |
11.3.2.Europe |
11.3.3.The Asia Pacific |
11.3.4.Latin America |
11.3.5.MEA |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. By Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.ECG Systems |
12.1.2.Holter Monitors |
12.1.3.Event Monitors |
12.1.4.Implantable Loop Recorders |
12.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Blood Tests |
12.2.2.Chest X-Ray |
12.2.3.Electrocardiogram (ECG) |
12.2.4.Echocardiogram |
12.2.5.Stress Test |
12.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI) |
12.2.7.Coronary Angiogram |
12.2.8.Myocardial Biopsy |
12.3. By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.North America |
12.3.2.Europe |
12.3.3.The Asia Pacific |
12.3.4.Latin America |
12.3.5.MEA |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Heart Failure Diagnostic And Monitoring Device Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. By Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.ECG Systems |
13.1.2.Holter Monitors |
13.1.3.Event Monitors |
13.1.4.Implantable Loop Recorders |
13.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Blood Tests |
13.2.2.Chest X-Ray |
13.2.3.Electrocardiogram (ECG) |
13.2.4.Echocardiogram |
13.2.5.Stress Test |
13.2.6.Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging (MRI) |
13.2.7.Coronary Angiogram |
13.2.8.Myocardial Biopsy |
13.3. By Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.North America |
13.3.2.Europe |
13.3.3.The Asia Pacific |
13.3.4.Latin America |
13.3.5.MEA |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Abbott Laboratories |
14.2.2.Beckman Coulter |
14.2.3.Abiomed Inc. |
14.2.4.Berlin Heart GmbH |
14.2.5.Biotronik SE and Co. KG |
14.2.6.Boston Scientific Corporation |
14.2.7.HeartWare International Inc. |
14.2.8.Jarvik Heart Inc. |
14.2.9.Medtronic plc |
14.2.10.Jude Medical |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players